BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2020
View Archived Issues
Novartis presents updated results from phase III COMBI-I study
Read More
First-in-human data show safety and early hemostatic efficacy of BAY-2599023
Read More
D6PV, a novel dual apoC-II mimetic peptide that lowers plasma triglycerides in vivo
Read More
Sumitomo Dainippon Pharma describes new Nav1.1 channel activators
Read More
Boehringer Ingelheim patents GABA(A) receptor subunits alpha5beta3gamma2 negative modulators
Read More
Thrombosis leads to early termination of phase II BAY-1093884 trial
Read More
Lentiviral IFN-alpha improves survival in mouse bladder cancer models
Read More
2019-nCoV more similar to bat than human SARS
Read More
CD47 knockout improves antitumor vaccine
Read More
Myelin is deregulated in autism spectrum disorder
Read More
Immunomic Therapeutics describes EBNA1-encoding cancer vaccine
Read More
AMT-060 gene therapy provides long-term factor IX activity in hemophilia B patients
Read More
Adverum reports new interim data from phase I trial of gene therapy ADVM-022 in wet AMD
Read More
Aerpio presents further phase Ib data on ocular formulation of AKB-9778
Read More
KSQ identifies novel target for development of eTIL therapies for refractory solid tumors
Read More
Gantenerumab arm of DIAN-TU study did not meet primary endpoint
Read More
New aflibercept 8 mg formulation to enter phase III trials for DME and wet AMD
Read More
Regeneron reports 2-year data from PANORAMA study of Eylea in diabetic retinopathy
Read More
Lilly reports topline results on solanezumab from DIAN-TU study
Read More